Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
gongxuening
- Development stage
- Phase 4
- Lead developer
- Yunnan Baiyao
- Administration
- Oral
01
Overview
Gongxuening is a Traditional Chinese Medicine (TCM) preparation derived from the rhizome of *Paris polyphylla* var. *yunnanensis* (Yunnan Paris). It is widely utilized in China for the management of various gynecological bleeding disorders, including menorrhagia, abnormal uterine bleeding (AUB), and hemorrhage following medical abortion or childbirth. The drug's primary active constituents are steroidal saponins, which exert hemostatic effects by promoting uterine smooth muscle contraction and inducing local vasoconstriction. Beyond its hemostatic properties, Gongxuening also exhibits anti-inflammatory and analgesic activities, which support its use in treating chronic pelvic inflammatory disease. It was developed and is primarily manufactured by the Yunnan Baiyao Group.
- Brand names
- GongxueningGongxuening Capsule
- Other names
- 宫血宁Gongxuening JiaonangGongxuening capsule
Beyond the preview
Go deeper on gongxuening.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on gongxuening.